Digestive Diseases and Sciences

, Volume 50, Issue 1, pp 163–166

Infliximab Therapy for Crohn’s Disease in a Patient with Chronic Hepatitis B

Authors

  • Yoshitaka Ueno
    • Department of EndoscopyHiroshima University Hospital
    • Department of EndoscopyHiroshima University Hospital
  • Masaru Shimamoto
    • Department of Medicine and Molecular ScienceHiroshima University
  • Yoshihiro Miyanaka
    • Department of Medicine and Molecular ScienceHiroshima University
  • Toru Hiyama
    • Health Service CenterHiroshima University
  • Masanori Ito
    • Department of Medicine and Molecular ScienceHiroshima University
  • Yasuhiko Kitadai
    • Department of Medicine and Molecular ScienceHiroshima University
  • Masaharu Yoshihara
    • Health Service CenterHiroshima University
  • Masaharu Sumii
    • Department of Medicine and Molecular ScienceHiroshima University
  • Kazuaki Chayama
    • Department of Medicine and Molecular ScienceHiroshima University
CASE REPORT

DOI: 10.1007/s10620-005-1295-8

Cite this article as:
Ueno, Y., Tanaka, S., Shimamoto, M. et al. Dig Dis Sci (2005) 50: 163. doi:10.1007/s10620-005-1295-8

KEY WORDS

Crohn’s diseaseinfliximabhepatitis B.

Copyright information

© Springer Science + Business Media, Inc. 2005